Biochem/physiol Actions
Primary TargetGhrelin receptor
General description
A 1, 2, 4-triazole derived compound that acts as a potent ghrelin receptor (GHS-R1a) antagonist (IC50 = 32 nM in a binding assay, dissociation constant Kb = 19 nM). Shown to reduce hexarelin-induced food intake [hexarelin (80 µg/kg, cumulative food intake (g of food/100 g of body weight) at 6 h by acute administration (sc) of JMV 2959 (160 µg/kg)] in rats without affecting the basal food intake. Also suppresses ghrelin and fasting-induced food intake at the level of the central nervous system. Reported to suppress genes up-regulated by ghrelin. Does not affect intracellular Ca2+ mobilization.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes
Moulin, A., et al. 2013. Amino Acids44, 301.Mary, S., et al. 2012. Proc Natl Acad Sci USA109, 8304.Salome, N., et al. 2009. Eur J Pharmacol.612, 167,.Moulin, A., et al. 2007. J Med Chem50, 579.
Packaging
Packaged under inert gas
10 mg in Glass bottle
Physical form
Supplied as a hydrochloride salt.
Reconstitution
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Warning
Toxicity: Standard Handling (A)
This product has met the following criteria to qualify for the following awards: